MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bezprozvanny, I.
Right arrow Articles by Tsien, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bezprozvanny, I.
Right arrow Articles by Tsien, R. W.

Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967)

I Bezprozvanny and RW Tsien

Department of Molecular and Cellular Physiology, Stanford University Medical Center, California 94305, USA.

Four different types of Ca2+ channel alpha 1 subunits, representing the major classes of voltage-gated Ca2+ channels, were individually coexpressed along with alpha 2/delta and beta 2b subunits in Xenopus oocytes. These subunits (and the encoded channel types and major tissues of origin) included alpha 1C (L-type, cardiac), alpha 1B (N- type, central nervous system), alpha 1A (P/Q-type, central nervous system), and alpha 1E (most likely R-type, central nervous system). Divalent cation currents through these channels (5 mM Ba2+) were evaluated with the two-microelectrode voltage-clamp technique. The expressed channels were compared with regard to their responses to a structurally novel, nondihydropyridine compound, mibefradil (Ro 40- 5967). In the micromolar concentration range, this drug exerted clear inhibitory effects on each of the four channel types, reducing divalent cation current at all test potentials, with the non-L-type channels being more sensitive to inhibition than the L-type channels under fixed experimental conditions. For all channel types, mibefradil was a much more effective inhibitor at more depolarized holding potentials, suggesting tighter binding of the drug to the inactivated state than to the resting state. The difference in apparent affinities of resting and inactivated states of the channels, calculated based on a modulated receptor hypothesis, was 30-70-fold. In addition, the time course of decay of Ca2+ channel current was accelerated in the presence of drug, consistent with open channel block. The effect of increasing stimulation frequency was tested for L-type channels and was found to greatly enhance the degree of inhibition by mibefradil, consistent with promotion of block by channel opening and inactivation. Allowing for state-dependent interactions, the drug concentrations found to block L- , N-, Q-, and R-type channels by 50% are at least 10-fold higher than half-blocking levels previously reported for T-type channels in vascular smooth muscle cells under similar experimental conditions. This may help explain the ability of the drug to spare working myocardium (strongly negative resting potential, dominance of L-type channels in their resting state) while reducing contraction in blood vessels (presumably involving T-type channels or partially inactivated L-type channels). Thus, mibefradil is a new addition to the family of nonselective organic Ca2+ channel inhibitors, as exemplified by bepridil and fluspirilene, and may prove useful as an experimental tool for studying diverse physiological events initiated by Ca2+ influx. It complements classes of drugs with relatively selective effects on L- type channels, as exemplified by nifedipine and diltiazem.

Volume 48, Issue 3, pp. 540-549, 09/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
I. Panek, U. Hoger, A. S. French, and P. H. Torkkeli
Contributions of Voltage- and Ca2+-Activated Conductances to GABA-Induced Depolarization in Spider Mechanosensory Neurons
J Neurophysiol, April 1, 2008; 99(4): 1596 - 1606.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Liu and M. T. Shipley
Multiple Conductances Cooperatively Regulate Spontaneous Bursting in Mouse Olfactory Bulb External Tufted Cells
J. Neurosci., February 13, 2008; 28(7): 1625 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Nikitina, Z.-D. Zhang, A. Kawashima, B. S. Jahromi, V. A. Bouryi, M. Takahashi, A. Xie, and R. L. Macdonald
Voltage-dependent calcium channels of dog basilar artery
J. Physiol., April 15, 2007; 580(2): 523 - 541.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Kim and L. O. Trussell
Ion Channels Generating Complex Spikes in Cartwheel Cells of the Dorsal Cochlear Nucleus
J Neurophysiol, February 1, 2007; 97(2): 1705 - 1725.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. G. Moldavan, R. P. Irwin, and C. N. Allen
Presynaptic GABAB Receptors Regulate Retinohypothalamic Tract Synaptic Transmission by Inhibiting Voltage-Gated Ca2+ Channels
J Neurophysiol, June 1, 2006; 95(6): 3727 - 3741.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Moosmang, N. Haider, B. Bruderl, A. Welling, and F. Hofmann
Antihypertensive Effects of the Putative T-Type Calcium Channel Antagonist Mibefradil Are Mediated by the L-Type Calcium Channel Cav1.2
Circ. Res., January 6, 2006; 98(1): 105 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. M. Swensen and B. P. Bean
Robustness of Burst Firing in Dissociated Purkinje Neurons with Acute or Long-Term Reductions in Sodium Conductance
J. Neurosci., April 6, 2005; 25(14): 3509 - 3520.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Zhang, A. Maximov, Y. Fu, F. Xu, T.-S. Tang, T. Tkatch, D. J. Surmeier, and I. Bezprozvanny
Association of CaV1.3 L-Type Calcium Channels with Shank
J. Neurosci., February 2, 2005; 25(5): 1037 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. L. Jensen, U. G. Friis, P. B. Hansen, D. Andreasen, T. Uhrenholt, J. Schjerning, and O. Skott
Voltage-dependent calcium channels in the renal microcirculation
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1368 - 1373.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Huang, B. M. Keyser, T. M. Tagmose, J. B. Hansen, J. T. Taylor, H. Zhuang, M. Zhang, D. S. Ragsdale, and M. Li
NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A New Selective Inhibitor of T-Type Calcium Channels
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 193 - 199.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
V. Egger, K. Svoboda, and Z. F. Mainen
Mechanisms of Lateral Inhibition in the Olfactory Bulb: Efficiency and Modulation of Spike-Evoked Calcium Influx into Granule Cells
J. Neurosci., August 20, 2003; 23(20): 7551 - 7558.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. K. Cloues and W. A. Sather
Afterhyperpolarization Regulates Firing Rate in Neurons of the Suprachiasmatic Nucleus
J. Neurosci., March 1, 2003; 23(5): 1593 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. Benquet, J. Le Guen, Y. Pichon, and F. Tiaho
Differential Involvement of Ca2+ Channels in Survival and Neurite Outgrowth of Cultured Embryonic Cockroach Brain Neurons
J Neurophysiol, September 1, 2002; 88(3): 1475 - 1490.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Hirooka, G. E. Bertolesi, M. E. M. Kelly, E. M. Denovan-Wright, X. Sun, J. Hamid, G. W. Zamponi, A. E. Juhasz, L. W. Haynes, and S. Barnes
T-Type Calcium Channel alpha 1G and alpha 1H Subunits in Human Retinoblastoma Cells and Their Loss After Differentiation
J Neurophysiol, July 1, 2002; 88(1): 196 - 205.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Lenglet, E. Louiset, C. Delarue, H. Vaudry, and V. Contesse
Activation of 5-HT7 Receptor in Rat Glomerulosa Cells Is Associated with an Increase in Adenylyl Cyclase Activity and Calcium Influx through T-Type Calcium Channels
Endocrinology, May 1, 2002; 143(5): 1748 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Wolfart and J. Roeper
Selective Coupling of T-Type Calcium Channels to SK Potassium Channels Prevents Intrinsic Bursting in Dopaminergic Midbrain Neurons
J. Neurosci., May 1, 2002; 22(9): 3404 - 3413.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Michels, J. Matthes, R. Handrock, U. Kuchinke, F. Groner, L. L. Cribbs, A. Pereverzev, T. Schneider, E. Perez-Reyes, and S. Herzig
Single-Channel Pharmacology of Mibefradil in Human Native T-Type and Recombinant Cav3.2 Calcium Channels
Mol. Pharmacol., March 1, 2002; 61(3): 682 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. M. Sanders
Signal Transduction in Smooth Muscle: Invited Review: Mechanisms of calcium handling in smooth muscles
J Appl Physiol, September 1, 2001; 91(3): 1438 - 1449.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ozawa, K. Hayashi, T. Nagahama, K. Fujiwara, and T. Saruta
Effect of T-Type Selective Calcium Antagonist on Renal Microcirculation: Studies in the Isolated Perfused Hydronephrotic Kidney
Hypertension, September 1, 2001; 38(3): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Perchenet and O. Clément-Chomienne
Characterization of Mibefradil Block of the Human Heart Delayed Rectifier hKv1.5
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 771 - 778.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. L. Martin, J.-H. Lee, L. L. Cribbs, E. Perez-Reyes, and D. A. Hanck
Mibefradil Block of Cloned T-Type Calcium Channels
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 302 - 308.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Wu, M. Zhang, P. A. Vest, A. Bhattacharjee, L. Liu, and M. Li
A Mibefradil Metabolite Is a Potent Intracellular Blocker of L-Type Ca2+ Currents in Pancreatic beta -Cells
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 939 - 943.
[Abstract] [Full Text]


Home page
CirculationHome page
G. J. Molderings, J. Likungu, and M. Gothert
N-Type Calcium Channels Control Sympathetic Neurotransmission in Human Heart Atrium
Circulation, February 1, 2000; 101(4): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Gomora, L. Xu, J. A. Enyeart, and J. J. Enyeart
Effect of Mibefradil on Voltage-Dependent Gating and Kinetics of T-Type Ca2+ Channels in Cortisol-Secreting Cells
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 96 - 103.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. C. Gomora, J. A. Enyeart, and J. J. Enyeart
Mibefradil Potently Blocks ATP-Activated K+ Channels in Adrenal Cells
Mol. Pharmacol., December 1, 1999; 56(6): 1192 - 1197.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Meder, K. Fink, J. Zentner, and M. Göthert
Calcium Channels Involved in K+- and Veratridine-Induced Increase of Cytosolic Calcium Concentration in Human Cerebral Cortical Synaptosomes
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1126 - 1131.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
L. O. Goodwin, N. B. Leeds, D. Guzowski, I. R. Hurley, R. G. Pergolizzi, and S. Benoff
Identification of structural elements of the testis-specific voltage dependent calcium channel that potentially regulate its biophysical properties
Mol. Hum. Reprod., April 1, 1999; 5(4): 311 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. Rossier, E. A. Ertel, M. B. Vallotton, and A. M. Capponi
Inhibitory Action of Mibefradil on Calcium Signaling and Aldosterone Synthesis in Bovine Adrenal Glomerulosa Cells
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 824 - 831.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. I. McDonough and B. P. Bean
Mibefradil Inhibition of T-Type Calcium Channels in Cerebellar Purkinje Neurons
Mol. Pharmacol., December 1, 1998; 54(6): 1080 - 1087.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. Bao, J. J. Li, and E. R. Perl
Differences in Ca2+ Channels Governing Generation of Miniature and Evoked Excitatory Synaptic Currents in Spinal Laminae I and II
J. Neurosci., November 1, 1998; 18(21): 8740 - 8750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Todorovic, M. Prakriya, Y. M. Nakashima, K. R. Nilsson, M. Han, C. F. Zorumski, D. F. Covey, and C. J. Lingle
Enantioselective Blockade of T-type Ca2+ Current in Adult Rat Sensory Neurons by a Steroid That Lacks gamma -Aminobutyric Acid-Modulatory Activity
Mol. Pharmacol., November 1, 1998; 54(5): 918 - 927.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
C. A. Muller, L. H. Opie, J. McCarthy, D. Hofmann, C. A. Pineda, and M. Peisach
Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 268 - 274.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Arnoult, M. Villaz, and H. M. Florman
Pharmacological Properties of the T-Type Ca2+ Current of Mouse Spermatogenic Cells
Mol. Pharmacol., June 1, 1998; 53(6): 1104 - 1111.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
S. M. Todorovic and C. J. Lingle
Pharmacological Properties of T-Type Ca2+ Current in Adult Rat Sensory Neurons: Effects of Anticonvulsant and Anesthetic Agents
J Neurophysiol, January 1, 1998; 79(1): 240 - 252.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Ito, N. Klugbauer, and F. Hofmann
Transfer of the High Affinity Dihydropyridine Sensitivity from L-Type To Non-L-Type Calcium Channel
Mol. Pharmacol., October 1, 1997; 52(4): 735 - 740.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J.-L. Morel, H. Drobecq, P. Sautiere, A. Tartar, J. Mironneau, J. Qar, J.-L. Lavie, and M. Hugues
Purification of a New Dimeric Protein from Cliona vastifica Sponge, which Specifically Blocks a Non-L-Type Calcium Channel in Mouse Duodenal Myocytes
Mol. Pharmacol., June 1, 1997; 51(6): 1042 - 1052.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. W. Stocker, L. Nadasdi, R. W. Aldrich, and R. W. Tsien
Preferential Interaction of omega -Conotoxins with Inactivated N-type Ca2+ Channels
J. Neurosci., May 1, 1997; 17(9): 3002 - 3013.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Cai, J. G. Mulle, and D. T. Yue
Inhibition of Recombinant Ca2+ Channels by Benzothiazepines and Phenylalkylamines: Class-Specific Pharmacology and Underlying Molecular Determinants
Mol. Pharmacol., May 1, 1997; 51(5): 872 - 881.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Hering, S. Aczel, M. Grabner, F. Doring, S. Berjukow, J. Mitterdorfer, M. J. Sinnegger, J. Striessnig, V. E. Degtiar, Z. Wang, et al.
Transfer of High Sensitivity for Benzothiazepines from L-type to Class A (BI) Calcium Channels
J. Biol. Chem., October 4, 1996; 271(40): 24471 - 24475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Wennemuth, R. E. Westenbroek, T. Xu, B. Hille, and D. F. Babcock
CaV2.2 and CaV2.3 (N- and R-type) Ca2+ Channels in Depolarization-evoked Entry of Ca2+ into Mouse Sperm
J. Biol. Chem., July 7, 2000; 275(28): 21210 - 21217.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. B. Hansen, B. L. Jensen, D. Andreasen, and O. Skott
Differential Expression of T- and L-Type Voltage-Dependent Calcium Channels in Renal Resistance Vessels
Circ. Res., September 28, 2001; 89(7): 630 - 638.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics